SF
SAGE

Synovus Financial’s Sage Therapeutics SAGE Stock Holding History

Synovus Financial’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-41
Closed -$2K – 1299
2020
Q2 		$2K Sell
41
-12
-23% -$436 ﹤0.01% 1440
2020
Q1 		$1K Buy
53
+12
+29% +$695 ﹤0.01% 2066
2019
Q4 		$3K Hold
41
– – ﹤0.01% 1390
2019
Q3 		$6K Hold
41
– – ﹤0.01% 1266
2019
Q2 		$8K Hold
41
– – ﹤0.01% 1161
2019
Q1 		$7K Hold
41
– – ﹤0.01% 1177
2018
Q4 		$4K Hold
41
– – ﹤0.01% 1236
2018
Q3 		$6K Buy
+41
New +$6.33K ﹤0.01% 1211

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return